Xu HB, Zhang YJ, Wei WJ, Li WM, Tu XQ. Pancreatic tumor: DSA diagnosis and treatment. World J Gastroenterol 1998; 4(1): 80-81 [PMID: 11819240 DOI: 10.3748/wjg.v4.i1.80]
Corresponding Author of This Article
Dr. Hong-Bing Xu, Department of Hepatobiliary Surgery, Chinese PLA 309 Hospital, Beijing 100091, China
Article-Type of This Article
Original Articles
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Gastroenterol. Feb 15, 1998; 4(1): 80-81 Published online Feb 15, 1998. doi: 10.3748/wjg.v4.i1.80
Pancreatic tumor: DSA diagnosis and treatment
Hong-Bing Xu, Yi-Jun Zhang, Wen-Jiang Wei, Wei-Min Li, Xiang-Qun Tu
Hong-Bing Xu, Wei-Min Li, Xiang-Qun Tu, Department of Hepatobiliary Surgery, Chinese PLA 309 Hospital, Beijing 100091, China
Yi-Jun Zhang, Department of Radiology, Chinese PLA 309 Hospital, Beijing 100091, China
Wen-Jiang Wei, Beijing North Municipal Tumor Hospital, Beijing 100091, China XU Hong-Bing, male, born on 1955-02-23, in Raoyang County, Hebei Province, graduated from the Second Military Medical University in 1978, Professor, Chief Surgeon, Vice-Director of Department of Surgery, having 70 papers and five books published.
Author contributions: All authors contributed equally to the work.
Correspondence to: Dr. Hong-Bing Xu, Department of Hepatobiliary Surgery, Chinese PLA 309 Hospital, Beijing 100091, China
Telephone: +86-10-66767729-4993
Received: July 22, 1997 Revised: September 11, 1997 Accepted: October 16, 1997 Published online: February 15, 1998
Abstract
AIM: To study the clinical significance of the diagnosis and catheterized interventional treatment of digital subtraction angiography (DSA) for pancreatic tumors.
METHODS: Ninety-two patients with pancreatic tumor, 69 males and 23 females, aged from 41 to 70 years (mean 57.1 years) were diagnosed with DSA. Sixty-one patients with pancreatic cancer were treated with transcatheter celiac and superior mesenteric arterial anticancer agents (MMC 20 mg, EADM 40 mg and 5-FU 2.0 g) infusion (TCSAI).
RESULTS: The DSA diagnoses were confirmed by operations and pathological examinations, with a coincidence 82.6% rate of, and a therapeutic effective rate of 42.6%.
CONCLUSION: DSA is of diagnostic value for pancreatic tumors, and helpful in understanding the course of the disease, judging the prognosis and selecting the therapeutic regimen, and could improve the chemotherapeutic effect as well.
